Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Dow Chemical has agreed to sell its specialty films business to Illinois-based Transilwrap. The Dow business makes blown oriented polystyrene and polyolefin films at plants in Hebron, Ohio, and Drusenheim, France.
KMG Chemicals has acquired Nagase FineChem, a Singapore-based producer of process chemicals for the liquid-crystal display and semiconductor industries with sales of $8 million in 2015. Texas-based KMG says the purchase will strengthen its electronic chemicals business in Asia.
Southern Oil Refining will build a $12 million pilot plant to produce “bio crude oil” from sugarcane bagasse and, potentially, prickly acacia in Gladstone, Australia. If the pilot is successful, the Australian firm will build a $115 million plant that will produce 200 million L per year.
Taiyo Nippon Sanso has acquired a stake in Jilin OLED Material, a Chinese manufacturer of materials for organic light-emitting diodes. The deal grants the Japanese firm exclusive sales rights to Jilin’s products outside China. Taiyo plans to bundle Jilin materials with its own products.
National Silicon Industry Group of China has offered to buy the Finnish silicon wafer maker Okmetic for more than $190 million. With a plant in Finland and contractors in China and Japan, Okmetic produces silicon wafers used in making sensors, discrete semiconductors, and analog circuits.
Bind Therapeutics will cut its workforce by 38%, to 61 employees. The firm announced the move along with inconclusive data from Phase II trials for its lead product, the cancer treatment BIND-014. Bind, which uses polymeric nanoparticles to deliver drugs, says it is considering other changes.
Johnson & Johnson will develop Tesaro’s PARP inhibitor niraparib for prostate cancer. J&J will pay a $35 million up-front fee and will take an equity stake worth $50 million in the biotech firm. Tesaro paid Merck & Co. just $7 million in 2012 for the rights to niraparib, which is currently in Phase III studies in ovarian and breast cancer.
Array Biopharma will license its small-molecule tropomyosin receptor kinase A inhibitors, including ARRY-954, to Asahi Kasei Pharma for $12 million plus up to $64 million in milestone payments. In in vivo models, the inhibitors block peripheral pain responses, Array says.
Advertisement
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter